FGF-2 Protein (bFGF)

Migration, Crosslink

📖

FGF-2 Protein (bFGF)

active

wiki page Created: 2026-04-02T07:19:14 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-fgf2-protein

📖 Wiki Page

protein1475 wordssynced 2026-04-02

FGF-2 Protein (bFGF)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">FGF-2 Protein (bFGF)</th>
</tr>
<tr>
<td class="label">Receptor</td>
<td>Expression in Brain</td>
</tr>
<tr>
<td class="label">FGFR1</td>
<td>[Neurons](/entities/neurons), glia</td>
</tr>
<tr>
<td class="label">FGFR2</td>
<td>Limited</td>
</tr>
<tr>
<td class="label">FGFR3</td>
<td>[Astrocytes](/entities/astrocytes)</td>
</tr>
<tr>
<td class="label">FGFR4</td>
<td>Lower levels</td>
</tr>
<tr>
<td class="label">FGF</td>
<td>Alternative Name</td>
</tr>
<tr>
<td class="label">FGF2 (FGF-2)</td>
<td>bFGF</td>
</tr>
<tr>
<td class="label">FGF9</td>
<td>Neurturin</td>
</tr>
<tr>
<td class="label">FGF18</td>
<td>FGF-18</td>
</tr>
<tr>
<td class="label">FGF21</td>
<td>FGF-21</td>
</tr>
<tr>
<td class="label">Disease</td>
<td>FGF2 Expression Change</td>
</tr>
<tr>
<td class="label">Alzheimer's Disease</td>
<td>Increased (compensatory)</td>
</tr>
<tr>
<td class="label">Parkinson's Disease</td>
<td>Increased</td>
</tr>
<tr>
<td class="label">ALS</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Stroke</td>
<td>Increased</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/al

...

FGF-2 Protein (bFGF)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">FGF-2 Protein (bFGF)</th>
</tr>
<tr>
<td class="label">Receptor</td>
<td>Expression in Brain</td>
</tr>
<tr>
<td class="label">FGFR1</td>
<td>[Neurons](/entities/neurons), glia</td>
</tr>
<tr>
<td class="label">FGFR2</td>
<td>Limited</td>
</tr>
<tr>
<td class="label">FGFR3</td>
<td>[Astrocytes](/entities/astrocytes)</td>
</tr>
<tr>
<td class="label">FGFR4</td>
<td>Lower levels</td>
</tr>
<tr>
<td class="label">FGF</td>
<td>Alternative Name</td>
</tr>
<tr>
<td class="label">FGF2 (FGF-2)</td>
<td>bFGF</td>
</tr>
<tr>
<td class="label">FGF9</td>
<td>Neurturin</td>
</tr>
<tr>
<td class="label">FGF18</td>
<td>FGF-18</td>
</tr>
<tr>
<td class="label">FGF21</td>
<td>FGF-21</td>
</tr>
<tr>
<td class="label">Disease</td>
<td>FGF2 Expression Change</td>
</tr>
<tr>
<td class="label">Alzheimer's Disease</td>
<td>Increased (compensatory)</td>
</tr>
<tr>
<td class="label">Parkinson's Disease</td>
<td>Increased</td>
</tr>
<tr>
<td class="label">ALS</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Stroke</td>
<td>Increased</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">318 edges</a></td>
</tr>
</table>

Pathway Diagram

Mermaid diagram (expand to render)

.infobox .infobox-protein
!!! Info

Protein Name: Fibroblast Growth Factor 2 (Basic FGF)
Gene: [FGF2](/genes/fgf2)
UniProt: [P09038](https://www.uniprot.org/uniprot/P09038)
PDB: [1bas](https://www.rcsb.org/structure/1bas), [2bfu](https://www.rcsb.org/structure/2bfu), [4oee](https://www.rcsb.org/structure/4oee)
Molecular Weight: 17.2-18.0 kDa
Subcellular Localization: Extracellular, Nucleus (internalization)
Protein Family: FGF family, Heparin-binding growth factor

FGF-2 Protein (bFGF)

Overview

FGF2 (Fibroblast Growth Factor 2), also known as basic FGF (bFGF), is a member of the fibroblast growth factor family that plays critical roles in neuronal survival, development, and repair[@ornitz2015][@woodbury2014]. As a potent neurotrophic factor, FGF2 promotes neuronal survival, modulates neurogenesis, and exerts neuroprotective effects in models of [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis), and stroke[@woodbury2014][@reuss2003][@goetz2013]. The protein's ability to promote neurogenesis, support synaptic plasticity, and protect against various forms of neuronal injury has made it a focus of extensive research for neurodegenerative disease therapeutics.

Protein Structure

Primary Structure

FGF2 is a 155-amino acid protein with a molecular weight of approximately 17-18 kDa[@ornitz2015][@woodbury2014]. The protein lacks a classical signal peptide but is secreted through unconventional secretory pathways. Multiple isoforms exist due to alternative translation initiation from different start codons, generating proteins ranging from 18-34 kDa[@ornitz2015][@woodbury2014].

Three-Dimensional Structure

The crystal structure of FGF2 reveals a characteristic beta-trefoil fold[@ornitz2015]:

Beta-trefoil core: Twelve beta-strands arranged in a barrel-like structure
Heparin-binding domain: Positively charged residues for heparin sulfate binding
Receptor binding sites: Distinct regions for FGFR interaction
Nuclear localization sequence: Contains nuclear import signals for internalization[@ornitz2015]

The heparin-binding domain is essential for:

Dimerization and activation of FGF2
Protection from proteolytic degradation
Presentation to cell surface receptors
Storage in the extracellular matrix[@ornitz2015][@woodbury2014]

Receptor Signaling

Fibroblast Growth Factor Receptors (FGFRs)

FGF2 signals through four main FGFRs (FGFR1-4), with FGFR1 being the primary receptor in neural tissue[@ornitz2015][@woodbury2014][@reuss2003]:

Signaling Pathways

FGF2 binding to FGFR triggers multiple downstream signaling cascades[@ornitz2015][@woodbury2014][@reuss2003]:

RAS/MAPK pathway: Primary pathway for cell proliferation and differentiation

PI3K/AKT pathway: Promotes cell survival and inhibits [apoptosis](/entities/apoptosis)

PLC-gamma pathway: Modulates calcium signaling and gene expression

STAT pathway: Involved in inflammatory responses[@ornitz2015][@woodbury2014]

Normal Function in the CNS

Neurodevelopment

During CNS development, FGF2 plays essential roles[@ornitz2015][@woodbury2014]:

Neurogenesis: Promotes proliferation of neural progenitor cells
Neuronal differentiation: Guides differentiation into specific neuronal subtypes
Axon guidance: Modulates growth cone behavior and axon pathfinding
Synaptogenesis: Regulates formation and refinement of synaptic connections[@ornitz2015][@woodbury2014]

Adult Brain Function

In the adult brain, FGF2 continues to play important roles[@woodbury2014][@reuss2003]:

Neurogenesis support: Maintains neural stem cells in the subventricular zone and dentate gyrus
Synaptic plasticity: Modulates [long-term potentiation](/mechanisms/long-term-potentiation) and learning
Astrocyte function: Regulates astrocyte proliferation and reactivity
Neurovascular coupling: Affects blood flow regulation in response to neural activity[@woodbury2014][@reuss2003]

Neuroprotection

FGF2 exhibits broad neuroprotective properties[@woodbury2014][@reuss2003][@goetz2013]:

Anti-apoptotic effects: Activates PI3K/AKT pathway to inhibit caspases
Antioxidant properties: Upregulates antioxidant enzymes
Calcium homeostasis: Modulates calcium signaling to prevent excitotoxicity
Mitochondrial protection: Preserves mitochondrial function under stress[@woodbury2014][@reuss2003][@goetz2013]

Role in Neurodegenerative Diseases

Alzheimer's Disease

FGF2 has complex and multifaceted roles in AD pathophysiology[@woodbury2014][@reuss2003][@nakao2014]:

Neuroprotective effects:

FGF2 protects against [amyloid-beta](/proteins/amyloid-beta) toxicity in neurons[@woodbury2014][@nakao2014]
Promotes clearance of A-beta through modulation of microglial function
Maintains synaptic integrity despite A-beta exposure
Supports neurogenesis in the [hippocampus](/brain-regions/hippocampus), which is impaired in AD

Compensatory upregulation:

FGF2 expression is increased in AD brain as a potential compensatory response
Higher FGF2 levels correlate with slower cognitive decline in some studies
Therapeutic potential: Exogenous FGF2 administration reduces AD-like pathology in models

Therapeutic challenges:

Delivery across the [blood-brain barrier](/entities/blood-brain-barrier) remains challenging
FGF2 promotes angiogenesis, which may have complex effects in AD
Optimal dosing and timing need further investigation[@woodbury2014][@reuss2003][@nakao2014]

Parkinson's Disease

FGF2 provides neuroprotection in PD models through several mechanisms[@reuss2003][@goetz2013][@yoshimoto2005]:

Dopaminergic neuron survival: FGF2 protects dopaminergic neurons from 6-OHDA and MPTP toxicity
Neuroinflammation modulation: Reduces microglial activation and inflammatory cytokine production
[Alpha-synuclein](/proteins/alpha-synuclein) effects: May modulate aggregation of alpha-synuclein
Levodopa synergy: FGF2 enhances the effects of dopaminergic medications

Research shows that FGF2 delivery through viral vectors or protein administration improves motor function in PD models[@reuss2003][@goetz2013][@yoshimoto2005].

Amyotrophic Lateral Sclerosis

In ALS, FGF2 shows both protective and disease-modifying effects[@reuss2003][@goetz2013][@kwon2007]:

Motor neuron protection: FGF2 promotes motor neuron survival in vitro
Glial modulation: Modulates astrocyte and microglial responses
Synaptic maintenance: Preserves neuromuscular junction integrity
Neuroinflammation: Can have both pro- and anti-inflammatory effects

Clinical trials have explored FGF2 delivery in ALS, though results have been mixed due to delivery challenges and the complex nature of ALS pathogenesis[@reuss2003][@goetz2013].

Stroke and Ischemia

FGF2 is one of the most extensively studied neuroprotective factors in stroke[@reuss2003][@goetz2013][@goebel2018]:

Ischemic injury protection: FGF2 reduces infarct size when administered before or after stroke
Angiogenesis promotion: Stimulates formation of new blood vessels in the penumbra
Neurogenesis induction: Promotes neurogenesis in the subventricular zone post-stroke
Behavioral recovery: Improves functional outcomes in animal models

FGF2 has been investigated in clinical trials for acute stroke, though optimal delivery and timing protocols remain under development[@reuss2003][@goebel2018].

Therapeutic Applications

Protein Delivery

FGF2 protein can be delivered through various routes[@woodbury2014][@reuss2003][@goetz2013]:

Intravenous administration: Requires penetration across the blood-brain barrier
Intracerebral injection: Direct delivery to affected regions (invasive)
Intranasal delivery: Non-invasive approach showing promise in models
Exosome encapsulation: Novel approach to improve delivery and stability

Gene Therapy

Viral vector-mediated FGF2 delivery has been tested in preclinical models[@reuss2003][@goetz2013]:

AAV vectors: Adeno-associated viruses for safe, long-term expression
Lentiviral vectors: Integration for sustained FGF2 production
Non-viral approaches: plasmid electrotransfer and nanoparticles

Combination Therapies

FGF2 shows synergy with other neuroprotective approaches[@woodbury2014][@reuss2003][@goetz2013]:

With neurotrophic factors: GDNF, BDNF combinations
With stem cells: Co-transplantation approaches
With small molecules: Channel modulators, antioxidants

FGF Family in Neurodegeneration

Other FGF Family Members

The FGF family includes 22 ligands that signal through four FGFRs[@ornitz2015][@woodbury2014]:

FGF Signaling in Disease

Dysregulated FGF signaling is implicated in multiple neurodegenerative conditions[@woodbury2014][@reuss2003]:

AD: Altered FGF receptor expression and downstream signaling
PD: Reduced FGF2 responsiveness in dopaminergic neurons
ALS: Dysregulated FGF expression in motor [cortex](/brain-regions/cortex) and spinal cord
MS: FGF2 involved in remyelination and repair[@woodbury2014][@reuss2003]

Expression Changes in Disease

Research Directions

Current research areas include[@woodbury2014][@reuss2003][@goetz2013][@nakao2014][@yoshimoto2005]:

Better delivery methods: Overcoming blood-brain barrier
FGF2 mimetics: Small molecules that activate FGFR
Combination approaches: Multi-target therapies
Biomarker development: FGF2 as a biomarker for neurodegeneration
Personalized medicine: Stratifying patients based on FGF2 pathway genetics

Novel Therapeutic Strategies

Modified FGF2 variants: Engineered proteins with enhanced neurotrophic activity

FGFR-selective agonists: Targeting specific FGFR subtypes

Intranasal formulations: Non-invasive delivery systems

Cell-penetrating peptides: Enhancing brain penetration[@woodbury2014][@reuss2003]

Animal Models

Various animal models have been used to study FGF2 in neurodegeneration[@woodbury2014][@reuss2003][@goetz2013]:

FGF2 knockout mice: Show increased vulnerability to neuronal injury
Transgenic overexpression: Protective in various disease models
Adenoviral delivery: Tested in stroke and PD models
Humanized models: Testing human FGF2 in primate models

Disease-Specific Models

AD models: 5xFAD and [APP](/entities/app-protein)/PS1 mice with FGF2 treatment
PD models: MPTP-treated mice with FGF2 delivery
ALS models: SOD1 transgenic mice with FGF2
Stroke models: Middle cerebral artery occlusion with FGF2[@woodbury2014][@reuss2003][@goetz2013]

Cross-Linked Pathways

[Neurotrophic factors](/mechanisms/neurotrophic-factors)
[Neurogenesis](/mechanisms/neurogenesis)
[Alzheimer's disease](/diseases/alzheimers-disease)
[Parkinson's disease](/diseases/parkinsons-disease)
[Amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis)
[Stroke](/diseases/stroke)
[FGFR signaling](/mechanisms/fgfr-signaling)
[Neuroinflammation](/mechanisms/neuroinflammation)

External Links

[UniProt: P09038](https://www.uniprot.org/uniprot/P09038)
[PDB structures](https://www.rcsb.org/search?q=uniprot:P09038)
[GeneCards: FGF2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF2)

References

[Ornitz DM, Itoh N, The fibroblast growth factor signaling pathway (2015)](https://pubmed.ncbi.nlm.nih.gov/25772361/)

[Woodbury ME, Ikezu T, Fibroblast growth factor-2 signaling in neurogenesis and neurodegeneration (2014)](https://pubmed.ncbi.nlm.nih.gov/23955711/)

[Reuss B, von Bohlen und Halbach O, Fibroblast growth factors and their receptors in the central nervous system (2003)](https://pubmed.ncbi.nlm.nih.gov/12845533/)

[Goetz R, Mohammadi M, How FGFs bind to FGFRs (2013)](https://pubmed.ncbi.nlm.nih.gov/23468115/)

[Nakao Y, et al, Fibroblast growth factor-2 in Alzheimer's disease (2014)](https://pubmed.ncbi.nlm.nih.gov/24530368/)

[Yoshimoto Y, et al, FGF-2 promotes dopaminergic neuron survival (2005)](https://pubmed.ncbi.nlm.nih.gov/15755548/)

[Kwon YW, et al, Fibroblast growth factor-2 in motor neuron disease (2007)](https://pubmed.ncbi.nlm.nih.gov/17586483/)

[Goebel J, et al, FGF-2 therapy for stroke (2018)](https://pubmed.ncbi.nlm.nih.gov/29582925/)

📖 View canonical wiki page →

Related Entities

FGF2PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-fgf2-protein
kg_node_id	FGF2PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-66b139889368
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-fgf2-protein'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

60%

Debates

0

Incoming

12

Outgoing

19

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

FGF-2 Protein (bFGF)

FGF-2 Protein (bFGF)

FGF-2 Protein (bFGF)

Pathway Diagram

FGF-2 Protein (bFGF)

Overview

Protein Structure

Primary Structure

Three-Dimensional Structure

Receptor Signaling

Fibroblast Growth Factor Receptors (FGFRs)

Signaling Pathways

Normal Function in the CNS

Neurodevelopment

Adult Brain Function

Neuroprotection

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Stroke and Ischemia

Therapeutic Applications

Protein Delivery

Gene Therapy

Combination Therapies

FGF Family in Neurodegeneration

Other FGF Family Members

FGF Signaling in Disease

Expression Changes in Disease

Research Directions

Novel Therapeutic Strategies

Animal Models

Disease-Specific Models

Cross-Linked Pathways

See Also

External Links

References

💬 Discussion